clinical trial operations
Better Clinical Trials Start with a Partner on the Inside
HIRO harnesses the innovation mindset of AMCs while streamlining institutional complexity by combining regulatory-grade data and centralized ClinOps from within a healthcare context. Instead of relying on a patchwork of third-party contract vendors, we provide you the clearest path to IRB approval, PI identification, study startup, and better patient outcomes.
Contact HIRO
We’re With You at Every Stage
1Planning and Design
Accelerate Study Startup
High-Fidelity Feasibility Data
Expedited IRB Approval
Single Source of Contracting
2Trial Operations
De-risk ClinOps and Recruitment
SME Protocol Review and Optimization
Automated Patient Qualification
PI Identification and Onboarding
3POST-TRIAL EVALUATION
Reach Real Patients Faster
Full Pipeline Optimization
Regulatory-Grade Evidence
Extended Patient Linkage
AMCs Are Essential Clinical Partners.
We Remove Their Complexity.
Academic Medical Centers can be complex partners, with siloed operations and cross-departmental stakeholders. But with world-class scientific talent and diverse patient populations, they are essential collaborators in your drug development journey. HIRO unlocks their therapeutic potential to match your commercial realities.
“The value of a single day of delay is worth approximately $500,000 in unrealized or lost prescription drug sales and $40,000 in direct daily clinical trial costs.”
Based on Tufts CSDD 2024 analysis of delayed study startup costs.
HIRO Accelerates Study Startup by
25
%
Compared to Traditional AMC Partnerships.
Partnering with HIRO
Myself and the team have had a great experience. The start-up process for such a large institution has been extremely efficient. The team has made themselves very available, which has directly impacted the success of our study at the site level.
Partnering with HIRO
The HIRO team was very helpful—systematic, open to feedback, and easy to work with. Their support was instrumental across multiple areas, including study startup, recruitment strategies, and sponsor communications. I appreciated their guidance and responsiveness throughout the process.
Partnering with HIRO
The partnership with HIRO is transforming the way we work directly with one of our most valuable clinical trial sites. We are already seeing early signs of success across multiple phase III clinical trial programs with reduced time of site set-up, and improved visibility into pre-enrollment activities and specific patient cohorts.
Partnering with HIRO
Their commitment to translating medical discoveries into patient care, paired with practical expertise, helps [our] research move forward at every phase. HIRO’s data-driven approach and patient-focused mindset consistently set them apart from other academic institutions.